Suppr超能文献

[其他降尿酸药物]

[Other antihyperuricemic agents].

作者信息

Ogino Kazuhide, Igawa Osamu, Hisatome Ichiro

机构信息

Center for Clinical Residency Program, Tottori University Hospital.

出版信息

Nihon Rinsho. 2008 Apr;66(4):754-7.

Abstract

It has been reported that hyperuricemia might be responsible for cardiovascular diseases as well as gout and renal injury. Hypertension and hyperlipidemia, which are also responsible for cardiovascular diseases, are often associated with hyperuricemia. Thus, the treatment of hypertension and hyperlipidemia associated with hyperuricemia is also important. Losartan, an antihypertensive agent, and fenofibrate, an antihyperlipidemic agent, are known to have uric acid lowering effects. Both agents are useful for hyperuricemia with associated with hypertension and hyperlipidemia. In this section, we reported the characteristics and usefulness of these two agents in hyperuricemic patients with hypertension and hyperlipidemia.

摘要

据报道,高尿酸血症可能是心血管疾病、痛风及肾损伤的病因。同样是心血管疾病病因的高血压和高脂血症,常与高尿酸血症相关。因此,治疗与高尿酸血症相关的高血压和高脂血症也很重要。抗高血压药物氯沙坦及抗高脂血症药物非诺贝特已知具有降低尿酸的作用。这两种药物对伴有高血压和高脂血症的高尿酸血症均有效。在本节中,我们报告了这两种药物在伴有高血压和高脂血症的高尿酸血症患者中的特点及效用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验